Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (91% of net sales) and internationally (9%). At the end of August 2024, the activity is carried out through 12,248 outlets (of which 8,560 located in the United States, Puerto Rico and the US Virgin Islands), 464 healthcare locations and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84.1%), Germany (8.2%), the United Kingdom (6.5%) and other (1.2%).

Employees

252,500

Sector

Drug Retailers

Calendar

12-31 - Q1 2026 Earnings Release (Projected)

More about the company

Analysis / Opinion

Walgreens: From Pharmacy Powerhouse to Private Equity Play

March 28, 2025 at 05:13 am

Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending

March 28, 2024 at 03:51 pm

More Strategies

09-02	Shields Health Solutions operating as a private standalone company following its acquisition by Sycamore Partners	RE
09-02	Cigna's unit to invest $3.5 billion in specialty pharmacy firm Shields	RE
08-28	Walgreens Boots Alliance, Inc. Announces Management Changes	CI
08-28	Sector Update: Health Care Stocks Softer Late Afternoon	MT
08-28	Sector Update: Health Care Stocks Decline Thursday Afternoon	MT
08-28	Sycamore Partners Management, L.P completed the acquisition of Walgreens Boots Alliance, Inc. from Stefano Pessina, his holding company,Alliance Santé Participations S.A and others.	CI
08-28	Walgreens names retail veteran Mike Motz as CEO after Sycamore takes chain private	RE
08-28	Walgreens names retail veteran Mike Motz as CEO after Sycamore takes chain private	RE
08-28	Walgreens Boots Alliance Goes Private After Sycamore Partners' Takeover	MT
08-28	The Chip on America's Shoulder
08-28	Walgreen Co. to operate as private standalone company following acquisition by Sycamore Partners	RE
08-28	Sycamore Partners completes acquisition of Walgreens Boots Alliance	RE
08-28	Blazing Star Reports Results of Walgreens Boots Alliance Cash Tender	MT

03-07	Jefferies Adjusts Walgreens Boots Alliance Price Target to $11.45 From $11	MT
03-07	RBC Capital Adjusts Walgreens Boots Alliance Price Target to $13 From $12	MT
03-07	UBS Adjusts Walgreens Boots Alliance Price Target to $11.45 From $11, Maintains Neutral Rating	MT
03-07	Evercore ISI Cuts Walgreens Boots Alliance Price Target to $11.45 From $12, Maintains In Line Rating	MT
03-07	Analyst recommendations: Bank of America, Macy's, Walgreens Boots, JP Morgan, VF Corp…

08-28	Sycamore Partners finishes deal to take drugstore chain Walgreens private	AQ
08-28	Walgreen Co. To Operate as Private Standalone Company Following Acquisition By Sycamore Partners	BU
08-28	Sycamore Partners Completes Acquisition of Walgreens Boots Alliance	BU
08-27	Blazing Star Merger Sub, Inc. announces final results for the previously announced Tender Offer and Consent Solicitation for any and all Walgreens Boots Alliance, Inc.'s 3.600% senior notes due 2025, 2.125% senior notes due 2026, 3.450% notes due 2026, 8.125% notes due 2029, 3.200% Notes due 2030, 4.500% senior notes due 2034, 4.800% senior notes due 2044, 4.650% notes due 2046 and 4.100% Notes due 2050, and any and all of Walgreen Co.'s 4.400% notes due 2042	PR
08-27	Blazing Star Merger Sub, Inc. announces extension of the expiration time for the previously announced Tender Offer and Consent Solicitation for any and all Walgreens Boots Alliance, Inc.'s 3.600% senior notes due 2025, 2.125% senior notes due 2026, 3.450% notes due 2026, 8.125% notes due 2029, 3.200% Notes due 2030, 4.500% senior notes due 2034, 4.800% senior notes due 2044, 4.650% notes due 2046 and 4.100% Notes due 2050, and any and all of Walgreen Co.'s 4.400% notes due 2042	PR

08-28	MÄRKTE USA/S&P-500 trotz Nvidia-Verlusten auf Allzeithoch
08-28	MÄRKTE USA/S&P-500 trotz Nvidia-Verlusten auf Rekordkurs
08-28	MÄRKTE USA/Wall Street trotz Nvidia-Verlusten knapp im Plus
08-28	Wall Street : Nvidia et la guerre des puces
08-28	MÄRKTE USA/Aktien behauptet erwartet - Nvidia vorbörslich etwas schwächer

Manager	Title	Age	Since
Mike Motz CEO	Chief Executive Officer	-	2025-08-27
Manmohan Mahajan DFI	Director of Finance/CFO	46	2023-07-26
Mike Maresca CTO	Chief Tech/Sci/R&D Officer	-	-

Walgreens Boots Alliance, Inc. Stock

Equities

WBA

US9314271084

Drug Retailers

Chart: Walgreens Boots Alliance, Inc.

Latest news: Walgreens Boots Alliance, Inc.

Last Transcript: Walgreens Boots Alliance, Inc.

Analysts' recommendations: Walgreens Boots Alliance, Inc.

Press Releases: Walgreens Boots Alliance, Inc.

News in other languages: Walgreens Boots Alliance, Inc.

Quotes and Performance

Managers and Directors: Walgreens Boots Alliance, Inc.

Other Drug Retailers

Company Profile

Analysis / Opinion

Director	Title	Age	Since
Timothy Wentworth BRD	Director/Board Member	65	2023-10-22
Stefano Pessina CHM	Chairman	84	2021-03-14
Stefan Kaluzny BRD	Director/Board Member	58	2025-08-27

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
WALGREENS BOOTS ALLIANCE, INC.	+0.50%	-1.72%	-	-	10.37B
JD HEALTH INTERNATIONAL INC.	-1.92%	-6.64%	+88.91%	-25.07%	23.57B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-1.53%	-4.64%	+41.99%	-34.85%	10.84B
MATSUKIYOCOCOKARA & CO.	-2.56%	-1.12%	+28.94%	+33.44%	7.41B
CLICKS GROUP LIMITED	+1.78%	+0.78%	-13.71%	+22.08%	4.76B
YIFENG PHARMACY CHAIN CO., LTD.	-1.72%	-8.57%	-15.15%	-42.76%	3.7B
NAHDI MEDICAL COMPANY	-3.07%	-3.56%	-20.50%	-43.41%	3.44B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-1.15%	+0.65%	-11.81%	+69.30%	2.92B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+0.06%	-0.63%	+7.03%	-49.80%	2.8B
GUARDIAN PHARMACY SERVICES, INC.	+1.59%	+6.70%	+39.57%	-	1.93B
Average	-0.80%	-0.67%	+16.14%	-8.88%	6.82B
Weighted average by Cap.	-1.17%	-2.36%	+42.94%	-14.48%